Cancer Research and Treatments
Cancer Research and Treatments is a research topic within Biotechnology. Science Explorer counts 48k research works in it since 1950. 14.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the use of engineered bacteria, particularly Salmonella typhimurium, for targeted cancer therapy. The research involves various strategies such as tumor-specific colonization, gene delivery, immunotherapy, and metabolic manipulation to induce tumor regression and enhance anti-tumor immunity. Fluorescent protein imaging is utilized to visualize tumor growth, metastasis, and angiogenesis in live animals. Additionally, the cluster explores the use of bacterial vectors for gene therapy and the potential of arginine deprivation as a targeted therapy for certain cancers.
- Bacterial Therapy
- Tumor Targeting
- Arginine Deprivation
- Fluorescent Protein Imaging
- Metastatic Cancer
- Gene Therapy
- Immunotherapy
- Salmonella Typhimurium
- Tumor Regression
- Cancer Metabolism
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 7.1k per year above
- Top-10% rate
- 14.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +4% the tick is no change
Which countries lead Cancer Research and Treatments research?
By volume, China and the United States publish the most (2.2k and 2k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.2k works
- 2 United States 2k works
- 3 Japan 343 works
- 4 India 321 works
- 5 Germany 243 works
- 6 South Korea 228 works
- 7 United Kingdom 198 works
- 8 France 161 works
- 9 Italy 152 works
- 10 Iran 148 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cancer Research and Treatments research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Cancer Research and Treatments research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Sun Yat-sen University.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 73 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 41 works
- 3 Sun Yat-sen UniversityChina 36 works
- 4 Sichuan UniversityChina 29 works
- 5 University of California San DiegoUnited States 28 works
- 6 Shanghai Jiao Tong UniversityChina 26 works
- 7 University of North Carolina at Chapel HillUnited States 26 works
- 8 Memorial Sloan Kettering Cancer CenterUnited States 25 works
- 9 Soochow UniversityChina 25 works
- 10 Zhejiang UniversityChina 24 works
Who are the leading researchers in Cancer Research and Treatments?
The most-cited researchers publishing on Cancer Research and Treatments include Bert Vogelstein, David Botstein and Guido Kroemer.
- 1 Bert Vogelstein United States 7.1k citations
- 2 David Botstein United States 6.7k citations
- 3 Guido Kroemer France 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cancer Research and Treatments research done?
The largest centres of Cancer Research and Treatments research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Houston.
Largest cities, 2022–2025
Where it is the local speciality
- HoustonUS · 112.7 works6.2×
Location quotient: how much more of its research is in Cancer Research and Treatments than the world average.
Where is the best place to study Cancer Research and Treatments?
Among universities, judged by research, Soochow University, China Pharmaceutical University and Wuhan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Soochow UniversityChina | 51.5 | 45.7% | 4.3× | 25 | -28.6% |
| 2 | China Pharmaceutical UniversityChina | 47.4 | 29.7% | 9.2× | 14 | -34.0% |
| 3 | Wuhan UniversityChina | 44.7 | 47.7% | 2.2× | 20 | -38.0% |
| 4 | China Medical UniversityChina | 44.7 | 33.1% | 7.2× | 17 | -51.7% |
| 5 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 44.4 | 20.4% | 5.8× | 41 | -4.1% |
| 6 | University of Chinese Academy of SciencesChina | 44.1 | 46.9% | 0.9× | 12 | +64.0% |
| 7 | Southern Medical UniversityChina | 41.6 | 28.9% | 6.6× | 17 | -43.4% |
| 8 | Nanjing Medical UniversityChina | 40.0 | 28.9% | 5.1× | 19 | -14.6% |
| 9 | Sichuan UniversityChina | 37.7 | 30.8% | 2.3× | 29 | -18.5% |
| 10 | Sun Yat-sen UniversityChina | 37.5 | 24.7% | 3.1× | 36 | -30.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cancer Research and Treatments research growing?
Output in 2018–2022 was 4% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cancer Research and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.